Transcatheter interventional therapy for mitral regurgitation is rapidly advancing with expanding indications and new devices, offering a promising treatment option for structural heart disease.
This review highlights the rapid advancement and expanding indications of transcatheter interventional therapies for mitral regurgitation.
Mitral regurgitation (MR) is a common valvular heart diseasewhose prevalence continues to increase with population aging, posing a serious threat to human health in the advanced stages of the disease. Sole reliance on medication and traditional surgical treatments can no longer meet the therapeutic needs of all patients. Transcatheter interventional therapy is gradually emerging as a promising new treatment option. Recently, technologies for the transcatheter interventional treatment of MR have advanced rapidly, with expanding indications and a continuous stream of new devices. The field has entered a phase of accelerated development in the treatment of structural heart disease, demonstrating broad clinical prospects. This article reviews the key technologies and developmental trends in the current transcatheter interventional treatments for MR, aiming to provide a theoretical basis and rationale for the safe and standardized implementation and broader adoption of these technologies.
Wang et al. (Fri,) conducted a review in Mitral regurgitation. Transcatheter interventional therapy was evaluated. Transcatheter interventional therapy for mitral regurgitation is rapidly advancing with expanding indications and new devices, offering a promising treatment option for structural heart disease.